| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |